Survival Rate of Patients with Gastric Cancer and effective factors in two referral hospitals of Mashhad, Iran: A Multiple Regression Analysis

Authors

  • Zahra Yousefli Gastrology and Hepatology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Ladan Goshayeshi Assistant Professor, Department of Gastrology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Hamid Heidarian Miri Assistant Professor, Department of Epidemiology and Biostatistics, School of Public Health, Mashhad University of Medical Sciences, Mashhad, Iran
  • Naiemeh Farhangnezhad Department of Gastrology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Aida Ghofrani Gastrology and Hepatology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Zahra Dashti Gastrology and Hepatology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Ramin Hoseinzadeh Gastrology and Hepatology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Keywords:

Mashhad, Proportional Hazards Models, Stomach Neoplasms, Survival Rate

Abstract

Background: Gastric cancer (GC) is among the most prevalent cancers in both genders, and the survival rate constitutes a measure to evaluate the diagnosis and treatment of GC. Mashhad is a city located in the northern part of Iran where has been identified as a high incidence region for GC.  Objective: To determine survival rate of GC patients diagnosed in Mashhad and identify whether underling factors including demographic factors, family history, education, addiction and co-morbidities can affect survival rate. Methods: This cross-sectional study was conducted in two tertiary referral hospitals (Ghaem Hospital and Imamreza Hospital) in Mashhad. Patients were all diagnosed with GC from 2012 to 2016, and their status in 2019 was determined by data collected from the patients’ records in the hospitals and also by phone calls. Kaplan- Meier, Log-Rank test, and Cox Proportional Hazards Model, were used for data analysis using STATA 14.1 software. Results: Among 308 patients, 230 (74.7%) were male, and 78 (25.3%) were female. The mean of patients’ age and age at diagnosis time were 65.49 and 64.72 years, respectively. Survival proportion at first, third, and fifth year after diagnosis in both sexes using Kaplan-Meier were 0.63, 0.20, and 0.16. Univariate analysis showed that ethnicity (HR=1.58, p=0.034), addiction (HR=0.53, p=0.016), positive family history (HR=1.56, p=0.023), past medical history (HR=7.93, p=0.002) and education level (HR=0.44, p=0.045) had significant effect on survival rate. Multivariate analysis was somehow consistent with those results except for education level. (HR=9.33, p=0.013). Conclusion: Older age at diagnosis time, male sex, positive family history, coronary artery disease, diabetes mellitus, and hypertension can negatively influence the survival rate of gastric cancer patients, and these could be applied for improving the GC screening and treatment guidelines.

References

Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for

cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2020;70(4):313. doi:

3322/caac.21609.

Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in

Ardabil: results of a population-based cancer registry from Iran. International journal of cancer.

;107(1):113-8. Epub 2003/08/20. doi: 10.1002/ijc.11359. PMID: 12925965.

Babaei M, Mousavi S, Malek M, Tosi G, Masoumeh Z, Danaei N, et al. Cancer occurrence in Semnan

Province, Iran: results of a population-based cancer registry. Asian Pacific journal of cancer prevention:

APJCP. 2005;6(2):159-64. Epub 2005/08/17. PMID: 16101326.

Yazdizadeh B, Jarrahi AM, Mortazavi H, Mohagheghi MA, Tahmasebi S, Nahvijo A. Time trends in the

occurrence of major GI cancers in Iran. Asian Pacific journal of cancer prevention: APJCP. 2005;6(2):130-

Epub 2005/08/17. PMID: 16101320.

Amirkhah R, Naderi-Meshkin H, Mirahmadi M, Allahyari A, Sharifi HR. Cancer statistics in Iran: Towards

finding priority for prevention and treatment. 2017. 2017;3(2):12. Epub 2017-10-25. doi: 10.15562/tcp.42.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal

for clinicians. 2011;61(2):69-90. Epub 2011/02/08. doi: 10.3322/caac.20107. PMID: 21296855.

Sadjadi A, Nooraie M, Ghorbani A, Alimohammadian M, Zahedi MJ, Darvish-Moghadam S, et al. The

incidence of prostate cancer in Iran: results of a population-based cancer registry. Archives of Iranian

medicine. 2007;10(4):481-5. Epub 2007/10/02. doi: 07104/aim.0011. PMID: 17903053.

Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of

gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric

cardia cancer. Gut. 2008;57(3):298-305. Epub 2007/10/30. doi: 10.1136/gut.2007.137364. PMID:

Zare A, Mahmoodi M, Mohammad K, Zeraati H, Hosseini M, Holakouie Naieni K. Factors Affecting the

Survival of Patients with Gastric Cancer Undergone Surgery at Iran Cancer Institute: Univariate and

Multivariate Analyses. Iranian journal of public health. 2014;43(6):800-8. Epub 2015/06/26. PMID:

; PMCID: PMC4475599.

Ding Y-B, Chen G-Y, Xia J-G, Zang X-W, Yang H-Y, Yang L, et al. Correlation of tumor-positive ratio

and number of perigastric lymph nodes with prognosis of patients with surgically-removed gastric

carcinoma. World J Gastroenterol. 2004;10(2):182-5. doi: 10.3748/wjg.v10.i2.182. PMID: 14716818,

PMCid: PMC4716999

Veisani Y, Delpisheh A. Survival rate of gastric cancer in Iran; a systematic review and meta-analysis.

Gastroenterology and hepatology from bed to bench. 2016;9(2):78-86. Epub 2016/04/22. PMID: 27099666;

PMCID: PMC4833845.

Goshayeshi L, Hoseini B, Yousefli Z, Khooie A, Etminani K, Esmaeilzadeh A, et al. Predictive model for

survival in patients with gastric cancer. Electronic physician. 2017;9(12):6035-42. Epub 2018/03/22. doi:

19082/6035. PMID: 29560157; PMCID: PMC5843431.

Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer:

prognostic factors and implications for postoperative adjuvant therapy. Annals of surgical oncology.

;9(4):394-400. Epub 2002/05/03. PMID: 11986192.

Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma:

multivariate analysis of prognostic factors in 270 patients. Oncology. 2003;65(2):95-101. Epub 2003/08/22.

doi: 10.1159/000072332. PMID: 12931013.

Wang CS, Hsieh CC, Chao TC, Jan YY, Jeng LB, Hwang TL, et al. Resectable gastric cancer: operative

mortality and survival analysis. Chang Gung medical journal. 2002;25(4):216-27. Epub 2002/06/25. PMID:

Canyilmaz E, Soydemir G, Serdar L, Uslu GH, Sahbaz A, Colak F, et al. Evaluation of prognostic factors

and survival results in gastric carcinoma: single center experience from Northeast Turkey. International

journal of clinical and experimental medicine. 2014;7(9):2656-66. Epub 2014/10/31. PMID: 25356123;

PMCID: PMC4211773.

Yazdani-Charati J, Janbabaei G, Etemadinejad S, Sadeghi S, Haghighi F. Survival of patients with stomach

adenocarcinoma in North of Iran. Gastroenterology and hepatology from bed to bench. 2014;7(4):211-7.

Epub 2014/10/08. PMID: 25289135; PMCID: PMC4185875.

Ghadimi M, Mahmoodi M, Mohammad K, Zeraati H, Rasouli M, Sheikhfathollahi M. Family history of the

cancer on the survival of the patients with gastrointestinal cancer in northern Iran, using frailty models.

Electronic physician

Page 7837

BMC gastroenterology. 2011;11:104. Epub 2011/10/04. doi: 10.1186/1471-230x-11-104. PMID:

; PMCID: PMC3217861.

Otsuji E, Yamaguchi T, Sawai K, Sakakura C, Okamoto K, Takahashi T. Regional lymph node metastasis

as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma. The

American journal of gastroenterology. 1999;94(2):434-7. Epub 1999/02/18. doi: 10.1111/j.1572-

1999.873_b.x. PMID: 10022642.

Yagi Y, Seshimo A, Kameoka S. Prognostic factors in stage IV gastric cancer: univariate and multivariate

analyses. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese

Gastric Cancer Association. 2000;3(2):71-80. Epub 2002/05/02. PMID: 11984714.

Koizumi W, Kurihara M, Tanabe S, Kondo I, Yamazaki I, Nonaka M, et al. Advantages of Japanese

response criteria for estimating the survival of patients with primary gastric cancer. Gastric cancer : official

journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association.

;2(1):14-9. Epub 2002/04/17. doi: 10.1007/s101209900021. PMID: 11957065.

Enzinger PC, Mayer RJ. Gastrointestinal cancer in older patients. Semin Oncol. 2004;31(2):206-19. Epub

/04/28. PMID: 15112151.

Saidi RF, Bell JL, Dudrick PS. Surgical resection for gastric cancer in elderly patients: is there a difference

in outcome? The Journal of surgical research. 2004;118(1):15-20. Epub 2004/04/20. doi: 10.1016/s0022-

(03)00353-6. PMID: 15093711.

Baeradeh NA, Lotfi MH, Fallahzadeh H, Kargar S, Salman Roghani H. Survival Rate of Patients with

Stomach Cancer and its Effective Factors in Yazd Province. Journal of Community Health Research.

;3(4):278-87.

Downloads

Published

2021-12-07

Issue

Vol. 13 No. 2 (2021): April-June 2021

Section

Articles

License

Copyright (c) 2021 Knowledge Kingdom Publishing

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.